Integral Characterization of Defective BDNF/TrkB Signalling in Neurological and Psychiatric Disorders Leads the Way to New Therapies
Open accessThe DOI matches its Crossref record; 211 of the 212 references it cites were found in a registry or an index.
Abstract
Enhancement of brain-derived neurotrophic factor (BDNF) signalling has great potential in therapy for neurological and psychiatric disorders. This neurotrophin not only attenuates cell death but also promotes neuronal plasticity and function. However, an important challenge to this approach is the persistence of aberrant neurotrophic signalling due to a defective function of the BDNF high-affinity receptor, tropomyosin-related kinase B (TrkB), or downstream effectors. Such changes have been already described in several disorders, but their importance as pathological mechanisms has been frequently underestimated. This review highlights the relevance of an integrative characterization of aberrant BDNF/TrkB pathways for the rational design of therapies that by combining BDNF and TrkB targets could efficiently promote neurotrophic signalling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recombinant BDNF performs poorly in humans due to rapid degradation, limited brain penetration, and unstable exposure profiles [122,123,125].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [123]
Experimental — accuracy not yet measuredIn the citing paper
“The transcription of BDNF is dependent upon activation of the cyclic adenosine monophosphate (cAMP) response element binding protein (CREB) protein which plays a critical role in LTP and synaptic plasticity142, 143.”
From Dysregulation of adult hippocampal neuroplasticity in major depression: Pathogenesis and therapeutic implications (2022) · cites this paper as [143]
In the citing paper
“These changes decrease BDNF axonal transport, resulting in reduced availability of BDNF within the synaptic cleft and consequently diminished signaling through TrkB receptors [137, 138].”
From Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation (2019) · cites this paper as [138]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
The Neuroendocrinology of Stress: A Never Ending Story
Lightman, S. L. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01711.x · Cited by 3,566
A Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375 · cited 1×
“Simultaneously, it has been shown that the therapeutic effects of antidepressants require the action of the BDNF/TrkB pathway [152] and, furthermore, that centrally administered BDNF provides a similar effect to antidepressants in animal models of depression [153].”
BackgroundNestler, E. J., Barrot, M., DiLeone, R. J., Eisch, A. J., Gold, S. J., & Monteggia, L. M. (2002) · Neuron · doi:10.1016/s0896-6273(02)00653-0 · Cited by 3,217
Exercise: a behavioral intervention to enhance brain health and plasticity
Cotman, C. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02143-4 · Cited by 2,739 · cited 1×
“For example, physical exercise evokes a significant increase of BDNF levels in rat hippocampus and cerebral cortex [187] which is mediated by brain uptake of circulating insulin-like growth factor I (IGF-I) [188].”
BackgroundGordon, M. O. (2002) · Archives of Ophthalmology · doi:10.1001/archopht.120.6.714 · Cited by 2,626 · cited 1×
“The most important risk factor for glaucoma is intraocular pressure [169].”
BackgroundTrk Receptors: Roles in Neuronal Signal Transduction
Huang, E. J., & Reichardt, L. F. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161629 · Cited by 2,537 · cited 1×
“Binding of BDNF to TrkB-FL induces the receptor dimerization and activation, and results in the recruitment of proteins that trigger three main signal transduction cascades which are widely interconnected (Figure 1) [5].”
Background
Cited by
Items 101–128 of 128
Jo, Y., Webster, M. J., Kim, S., & Lee, D. (2023) · Briefings in Functional Genomics · doi:10.1093/bfgp/elad041 · Cited by 5
Çalışkan, H., & Karabulut, G. (2025) · Journal of Endocrinology · doi:10.1530/joe-25-0088 · Cited by 5
Stress Responsiveness of BDNF/TrkB Signaling in the Neuroendocrine System and Future Implications
Azogu‐Sepe, I., & Plamondon, H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813156-5.00013-3 · Cited by 5
“This complexity is related to a great diversity of biological systems that are activated and regulated by TrkB receptors and their downstream signaling pathways, as well as the distinct roles of cell surface signaling by BDNFbound TrkB receptors and endosomes that bind and internalize BDNF/TrkB complexes.(109) Besides…”
BackgroundInfluentialBautista-Perez, S. M., Silva‐Islas, C. A., Cárdenas‐Aguayo, M. D. C., Lora‐Marin, O., Silva‐Lucero, M., Avendaño‐Estrada, A., Avila-Rodriguez, M. A., Lara-Espinosa, J. V., Hernández‐Pando, R., Menes‐Arzate, M., et al. (2026) · Nutrients · doi:10.3390/nu18020362 · Cited by 2
Kazana, W., & Zabłocka, A. (2020) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.5604/01.3001.0014.5678 · Cited by 3
Gaber, A. M., Ahmed, O. M., Khadrawy, Y. A., Zoheir, K. M. A., Abo‐Eleneen, R. E., Alblihed, M. A., & El-Bakry, A. M. (2023) · Biology · doi:10.3390/biology12070905 · Cited by 3
“BDNF supports neuronal development and survival by inhibiting the expression of proapoptotic proteins and increasing the levels of neurofunctional proteins through the cyclic adenosine monophosphate response element-binding protein transcription pathway [63,64].”
BackgroundKritika, Sanjay, S., & Lee, H. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118362 · Cited by 1
Ma, R., Gong, J., Xie, X., Liang, S., Yang, Z., & Li, J. (2025) · Xenobiotica · doi:10.1080/00498254.2025.2566205 · Cited by 1
“BDNF exerts its effects by binding to its receptor TrkB; therefore, the expression levels of BDNF and its receptor TrkB can serve as direct indicators of an organism’s learning and memory functions (Tejeda and Díaz-Guerra 2017).”
Azadbakht, A. A., Mashayekhi‐Sardoo, H., & Baghcheghi, Y. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04619-0 · Cited by 6
“Potential therapies could involve the use of pharmacological agents that enhance BDNF expression or promote its signaling [ 121, 122], as well as lifestyle interventions such as exercise and dietary modifications that have been shown to boost BDNF levels [ 123].”
Kang, M. C., Wandel, S. M. D., Perez, C. N., Deutz, N. E. P., & ENGELEN, M. P. K. J. (2026) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2026.106561 · Cited by 1
Torres-Campos, E., Varela‐Nieto, I., & Díaz‐Guerra, M. (2026) · Molecular Medicine · doi:10.1186/s10020-026-01539-9 · Cited by 1
“…of this receptor has been implicated in other excitotoxicity-associated pathologies, including neurodegenerative diseases (Alzheimer’s or Parkinson’s), neuro-psychiatric disorders (depression or schizophrenia), and neurological conditions (epilepsy or stroke) (Tejeda and Diaz-Guerra 2017).”
Self-citationVitamin D - a key to reducing the risk of suicide?
Januszewski, J., Forma, A., Karakuła, K. H., Sitarz, R., Baj, J., Kłodnicka, K., Zembala, J., & Juchnowicz, D. (2023) · Current Problems of Psychiatry · doi:10.12923/2353-8627/2023-0015 · Cited by 1
Gutiérrez, M. C., Perondi, M. C., Tortoni, G. L., Cragnolini, A. B., Cuadra, G. R., & Valdomero, A. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110099 · Cited by 1
Shi, J., Yang, T., Li, Y., Zhong, L., Longo, F. M., & Massa, S. M. (2025) · Neurotrauma Reports · doi:10.1089/neur.2024.0117 · Cited by 1
Onufriev, M. V., Moiseeva, Y. V., Volobueva, M. N., Kvichansky, A. A., Tret’yakova, L. V., & Gulyaeva, N. V. (2021) · Neurochemical Journal · doi:10.1134/s1819712421020124 · Cited by 1
Beitchman, J. A., Griffiths, D. R., Hur, Y., Ogle, S. B., Hair, C. E., Morrison, H. W., Lifshitz, J., Adelson, P. D., & Thomas, T. C. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/640078 · Cited by 1
“5 All procedures and animal care were conducted in compliance with an approved Institutional Animal Care and Use Committee protocol (13-460) at the University of Arizona College of Medicine-Phoenix which is consistent with the National Institutes of Health (NIH) Guidelines for the Care and Use of Laboratory Animals.”
MethodSynaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery
Tanaka, M. (2026) · Biomedicines · doi:10.3390/biomedicines14061265
Molecular aspects of regeneration and neuroprotection in neurodegenerative diseases
Farooqui, A. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-821711-5.00007-3
Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine
Reischl, G. (2019) · MDPI eBooks · doi:10.3390/books978-3-03921-314-6
Gindin, S. (2021) · Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal · doi:10.26685/urncst.265
Hemasree, G. N. S., Satish, K. S., Rajalekshmi, S. G., Burri, R. R., & Murthy, T. P. K. (2023) · Molecular Diversity · doi:10.1007/s11030-023-10673-z
“TRKβ is highly expressed in brain regions (cerebral cortex, thalamus, brain stem, and hippocampus) and is reported to be downregulated in a number of neurological disorders (stroke, Alzheimer’s disease, Parkinson’s disease, Hungtington’s disease, and schizophrenia) [20].”
Smith, A. M. (2024) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2024-16189
Lee, H.-W., Chen, S.-J., Tsai, K.-J., Hsu, K.-S., Chen, Y.-F., Chang, C.-H., Lin, H.-H., Hsueh, W.-Y., Hsieh, H.-P., Lee, Y.-F., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26718306
Lee, H.-W., Chen, S.-J., Tsai, K.-J., Hsu, K.-S., Chen, Y.-F., Chang, C.-H., Lin, H.-H., Hsueh, W.-Y., Hsieh, H.-P., Lee, Y.-F., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26718303
Zhang, X., Chen, N., Zhu, X., & Wang, C. (2026) · Frontiers in Pediatrics · doi:10.3389/fped.2026.1826133
“These findings are in line with neurophysiological evidence showing that patients with Tourette syndrome exhibit impaired long-term potentiation (LTP)- and long-term depression (LTD)-like plasticity in the primary motor cortex, which reflects reduced BDNF-mediated synaptic adaptability (23, 24).”
Ommati, M. M., Rezaei, H., Song, S., Chang, R., Najibi, A., Maghami, S., Yousefipour, K., Niknahad, H., & Heidari, R. (2026) · Behavioural Brain Research · doi:10.1016/j.bbr.2026.116369
Naghizadeh, F., Niknazar, S., Dadseresht, A., Seidkhani, E., Alizadeh, R., & Arezo, N. (2026) · Research Square · doi:10.21203/rs.3.rs-11106755/v1
BindingDB Entry 50007770: Targeting tropomyosin receptor kinase for cancer therapy.
BindingDB (2021) · UC San Diego · doi:10.7270/q25m691t
Metadata
- Authors
- Tejeda, G., & Díaz-Guerra, M.
- Affiliations
- Consejo Superior de Investigaciones Científicas (ES)
- Instituto de Investigaciones Biomédicas “Alberto Sols”, Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid (CSIC-UAM), Arturo Duperier 4, 28029 Madrid, Spain
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2017-01-28
- Volume
- 18
- Issue
- 2
- Pages
- 268
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC5343804
- OpenAlex
- W2581435615
- Cited by
- 126
- References
- 212
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 16 · 2023: 16 · 2022: 13 · 2021: 13 · 2020: 20 · 2019: 13 · 2018: 10 · 2017: 4
- FWCI
- 1.58
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion, cc-by)
- Funders
- Ministerio de Economía y Competitividad, Spain (BFU2013-43808-R)
- Fundación Mutua Madrileña, Spain (201322001)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacological Receptor Mechanisms and Effects
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- brain-derived neurotrophic factor, TrkB receptor, BDNF/TrkB signaling, neurotrophin signaling, neurological disorders, mental illness, neurotrophic therapy, neuroplasticity, cell death
- MeSH terms
- Animals, Mental Disorders, Humans, Nervous System, Signal Transduction, Brain-Derived Neurotrophic Factor, Receptor, trkB, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.